Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function

Tyrosin kinase inhibitors (TKI) sharply improved the prognosis of Chronic Myeloid Leukemia (CML) and of Philadelphia(+) Acute Lymphoblastic Leukemia (Ph(+)ALL) patients. However, TKI are not curative because of the development of resistance and lack of complete molecular remission in the majority of...

Descripción completa

Detalles Bibliográficos
Autores principales: Damele, Laura, Montaldo, Elisa, Moretta, Lorenzo, Vitale, Chiara, Mingari, Maria Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207002/
https://www.ncbi.nlm.nih.gov/pubmed/30405627
http://dx.doi.org/10.3389/fimmu.2018.02433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207002/
https://www.ncbi.nlm.nih.gov/pubmed/30405627
http://dx.doi.org/10.3389/fimmu.2018.02433

Ejemplares similares